Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Market Cap	690.88M -14.9%
Revenue (ttm)	1.93B -21.6%
Net Income	19.24M -81.8%
EPS	0.02 -80.9%
Shares Out	863.60M
PE Ratio	34.24
Forward PE	n/a
Dividend	0.05 (5.88%)
Ex-Dividend Date	May 23, 2025

Volume	376,000
Average Volume	585,000
Open	0.8400
Previous Close	0.8500
Day's Range	0.8000 - 0.8500
52-Week Range	0.5000 - 1.0000
Beta	0.55
RSI	48.72
Earnings Date	Mar 26, 2026

About HKG:3737

Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China. The company operates through Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It also provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brand names. In addition, the company manufactures and sells food and Chinese herbs; offers detection and testing services; and manages properties. Fu...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 2,488
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3737

Financial Performance

In 2025, HKG:3737's revenue was 1.74 billion, a decrease of -21.55% compared to the previous year's 2.21 billion. Earnings were 17.29 million, a decrease of -81.84%.

Financial numbers in CNY